Shanghai Kehua Bio-Engineering Co Ltd (002022) — Cash Flow Reinvestment Rate
Shanghai Kehua Bio-Engineering Co Ltd (002022) has a Cash Flow Reinvestment Rate of 1.11x as of September 2025, reinvesting CN¥31.24 Million (capex CN¥31.24 Million ) from operating cash flow of CN¥28.25 Million. Explore 002022 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Kehua Bio-Engineering Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Shanghai Kehua Bio-Engineering Co Ltd across 22 annual periods. Also explore Shanghai Kehua Bio-Engineering Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Shanghai Kehua Bio-Engineering Co Ltd. For live market cap and broader valuation context, see 002022 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.79x | CN¥197.26 Million | CN¥22.44 Million | CN¥139.29 Million | ▲ +2165.4% |
| 2022 | 0.39x | CN¥835.73 Million | CN¥2.15 Billion | CN¥427.91 Million | ▲ +86.2% |
| 2021 | 0.21x | CN¥224.93 Million | CN¥1.08 Billion | CN¥216.03 Million | ▲ +9.1% |
| 2020 | 0.19x | CN¥261.20 Million | CN¥1.37 Billion | CN¥257.72 Million | ▼ -66.3% |
| 2019 | 0.57x | CN¥141.17 Million | CN¥248.87 Million | CN¥140.21 Million | ▼ -47.5% |
| 2018 | 1.08x | CN¥136.95 Million | CN¥126.79 Million | CN¥123.98 Million | ▲ +14.7% |
| 2017 | 0.94x | CN¥123.12 Million | CN¥130.71 Million | CN¥105.12 Million | ▲ +142.2% |
| 2016 | 0.39x | CN¥109.36 Million | CN¥281.25 Million | CN¥103.25 Million | ▼ -4.9% |
| 2015 | 0.41x | CN¥91.73 Million | CN¥224.30 Million | CN¥85.62 Million | ▲ +1.4% |
| 2014 | 0.40x | CN¥100.67 Million | CN¥249.64 Million | CN¥100.67 Million | ▲ +16.8% |
| 2013 | 0.35x | CN¥86.37 Million | CN¥250.22 Million | CN¥86.37 Million | ▲ +1.1% |
| 2012 | 0.34x | CN¥72.98 Million | CN¥213.74 Million | CN¥72.98 Million | ▲ +4.7% |
| 2011 | 0.33x | CN¥71.65 Million | CN¥219.80 Million | CN¥71.65 Million | ▲ +107.9% |
| 2010 | 0.16x | CN¥37.92 Million | CN¥241.83 Million | CN¥37.92 Million | ▼ -18.2% |
| 2009 | 0.19x | CN¥41.71 Million | CN¥217.51 Million | CN¥41.71 Million | ▲ +49.1% |
| 2008 | 0.13x | CN¥17.70 Million | CN¥137.66 Million | CN¥17.70 Million | ▼ -18.5% |
| 2007 | 0.16x | CN¥17.81 Million | CN¥112.93 Million | CN¥17.81 Million | ▼ -45.1% |
| 2006 | 0.29x | CN¥25.08 Million | CN¥87.21 Million | CN¥25.08 Million | ▲ +52.8% |
| 2005 | 0.19x | CN¥13.92 Million | CN¥73.97 Million | CN¥13.92 Million | ▼ -79.5% |
| 2004 | 0.92x | CN¥44.69 Million | CN¥48.74 Million | CN¥44.69 Million | ▲ +160.3% |
| 2003 | 0.35x | CN¥24.86 Million | CN¥70.57 Million | CN¥24.86 Million | ▼ -29.0% |
| 2002 | 0.50x | CN¥20.57 Million | CN¥41.48 Million | CN¥20.57 Million | — |